SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Estimated Useful Life in Years for Property and Equipment

Diagnostic equipment	5–13
Research, development and demonstration equipment	3-7
Machinery and equipment	2-7
Furniture and fixtures	3-9
Leasehold improvements	3–10
Building	28

Patient Fee Revenue - Net

	For the Years Ended June 30
	2022		2021
Commercial Insurance/ Managed Care	$	4,248,708	$	4,100,440
Medicare/Medicaid		1,060,920		968,055
Workers’ Compensation/Personal Injury		17,907,335		15,011,111
Other		6,365,275		3,227,783
Net Patient Fee Revenue	$	29,582,238	$	23,307,389

Schedule of earnings per share

	June 30, 2022
Basic	Total		Common Stock		Class C Common Stock
Numerator:
Net income available to common stockholders	$	12,440,906	$	11,690,796	$	191,038
Denominator:
Weighted average shares outstanding		6,554,209		6,554,209		382,513
Basic income per common share	$	1.90	$	1.78	$	0.50
Diluted
Denominator:
Weighted average shares outstanding				6,554,209		382,513
Class C Common Stock				127,504		—
Total Denominator for diluted earnings per share				6,681,713		382,513
Diluted income per common share			$	1.75	$	0.50

	June 30, 2021
Basic	Total		Common Stock		Class C Common Stock
Numerator:
Net income available to common stockholders	$	10,207,588	$	9,592,134	$	156,744
Denominator:
Weighted average shares outstanding		6,505,283		6,505,283		382,513
Basic income per common share	$	1.57	$	1.47	$	0.41
Diluted
Denominator:
Weighted average shares outstanding				6,505,283		382,513
Class C Common Stock				127,504		—
Total Denominator for diluted earnings per share				6,632,787		382,513
Diluted income per common share			$	1.45	$	0.41